Silverarc Capital Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-121,274
| Closed | -$903K | – | 69 |
|
|
2024
Q4 | $903K | Buy |
121,274
+21,274
| +21% | +$158K | 0.2% | 51 |
|
|
2024
Q3 | $799K | Hold |
100,000
| – | – | 0.18% | 59 |
|
|
2024
Q2 | $870K | Sell |
100,000
-147,968
| -60% | -$1.29M | 0.21% | 57 |
|
|
2024
Q1 | $5.13M | Buy |
+247,968
| New | +$5.13M | 1.42% | 26 |
|
|
2022
Q4 | – | Sell |
-108,285
| Closed | -$857K | – | 87 |
|
|
2022
Q3 | $857K | Sell |
108,285
-89,355
| -45% | -$707K | 0.29% | 54 |
|
|
2022
Q2 | $1.56M | Buy |
197,640
+11,974
| +6% | +$94.2K | 0.48% | 37 |
|
|
2022
Q1 | $2.26K | Buy |
185,666
+3,780
| +2% | +$46 | 0.93% | 28 |
|
|
2021
Q4 | $2.23M | Buy |
181,886
+52,596
| +41% | +$644K | 0.9% | 35 |
|
|
2021
Q3 | $1.35M | Sell |
129,290
-113,019
| -47% | -$1.18M | 0.76% | 43 |
|
|
2021
Q2 | $2.18K | Sell |
242,309
-57,691
| -19% | -$519 | 0.97% | 35 |
|
|
2021
Q1 | $3.05M | Buy |
+300,000
| New | +$3.05M | 1.66% | 22 |
|